Big Tobacco Meets Big Pharma. What Could Go Wrong?

Tobacco giant Philip Morris International is in the mood to diversify.
 
Not into new e-cigarette brands but into the acquisition of drug delivery companies—including some that treat smoking-related illnesses.
 
The Quote: “It’s like someone breaking your knees and then selling you the crutches,” said COPD researcher Ruth Tal-Singer.
 
With falling smoking rates, the world’s largest listed tobacco company is looking, for example, to buy British drug firm Vectura, developer treatments for COPD (which is usually caused by smoking, per the CDC).
 
Advocacy organizations are protesting the sale.
 
The company argues that it’s doing what public health wants it to do: shift its revenues from cigarettes.
 
The Washington Post

Secondary Topic
Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top